Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus
Original scientific paper
DOI:
https://doi.org/10.5599/admet.3333Keywords:
Natural products, antimicrobial activity, bacterial infections, biofilm, toxicity, Galleria mellonellaAbstract
Background and purpose: Microbial resistance is a major global health concern. Methicillin-resistant Staphylococcus aureus is particularly relevant due to its clinical significance, virulence and adaptability. In the search for novel antimicrobial agents, natural products emerged as important sources of bioactive molecules. Previous studies have identified Hypericum brasiliense as a plant with promising antibacterial properties. Experimental approach: We evaluated the susceptibility, mechanisms of action and toxicity of H. brasiliense hexane extract (heHb) and the isolated compounds uliginosin B (uliB), isouliginosin B and japonicin A against reference and drug-resistant S. aureus isolates. Key results: The heHb and uliB demonstrated strong antibacterial activity, exhibiting MICs of 3.125 to 6.25 µg mL-1 and MBCs of 6.25 to 12.5 µg mL-1. Isouliginosin B displayed moderate activity (MIC = 12.5 µg mL-1; MBC ≤50 µg mL-1), whereas japonicin A was inactive. Transmission and scanning electron microscopy revealed pronounced ultrastructural alterations in bacterial cells following exposure to either heHb or uliB, and these exposures induced oxidative stress without compromising plasma membrane integrity. Conversely, the antioxidant N-acetylcysteine partially restored bacterial growth. Docking analysis suggested that uliB might act as a competitive substrate for the NADH-2 enzyme and cytochrome bd oxidase. Moreover, heHb and uliB inhibited biofilm formation and disrupted mature biofilms. Cytotoxicity assays (Vero and HaCaT lineages) showed CC₅₀ >90 µg mL-1, and haemolysis occurred only at the highest concentrations. In vivo assessment using Galleria mellonella confirmed low toxicity. ADMET predictions indicated a favourable pharmacokinetic profile for uliB. Conclusion: UliB is likely a key bioactive compound of H. brasiliense, with promising therapeutic potential against S. aureus.
Downloads
References
[1] A. Liu, S. Garrett, W. Hong, J. Zhang. Staphylococcus aureus Infections and Human Intestinal Microbiota. Pathogens 13 (2024) 276. https://doi.org/10.3390/pathogens13040276 DOI: https://doi.org/10.3390/pathogens13040276
[2] B.P. Howden, S.G. Giulieri, T. Wong Fok Lung, S.L. Baines, L.K. Sharkey, J.Y.H. Lee, A. Hachani, I.R. Monk, T.P. Stinear. Staphylococcus aureus host interactions and adaptation. Nature Reviews Microbiology 21 (2023) 380-395. https://doi.org/10.1038/s41579-023-00852-y DOI: https://doi.org/10.1038/s41579-023-00852-y
[3] S. Kumar, R.P. Mahato, S. Ch, S. Kumbham. Current strategies against multidrug-resistant Staphylococcus aureus and advances toward future therapy. The Microbe 6 (2025) 100281. https://doi.org/10.1016/j.microb.2025.100281 DOI: https://doi.org/10.1016/j.microb.2025.100281
[4] P. Piewngam, M. Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe 5 (2024) e606-e618. https://doi.org/10.1016/S2666-5247(24)00040-5 DOI: https://doi.org/10.1016/S2666-5247(24)00040-5
[5] A.G. Atanasov, S.B. Zotchev, V.M. Dirsch, the International Natural Product Sciences Taskforce, C.T. Supuran. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery 20 (2021) 200-216. https://doi.org/10.1038/s41573-020-00114-z DOI: https://doi.org/10.1038/s41573-020-00114-z
[6] N. Vaou, E. Stavropoulou, C. Voidarou, C. Tsigalou, E. Bezirtzoglou. Towards advances in medicinal plant antimicrobial activity: a review study on challenges and future perspectives. Microorganisms 9 (2021) 2041. https://doi.org/10.3390/microorganisms9102041 DOI: https://doi.org/10.3390/microorganisms9102041
[7] J. Dai, R. Han, Y. Xu, N. Li, J. Wang, W. Dan. Recent progress of antibacterial natural products: Future antibiotics candidates. Bioorganic Chemistry 101 (2020) 103922. https://doi.org/10.1016/j.bioorg.2020.103922 DOI: https://doi.org/10.1016/j.bioorg.2020.103922
[8] A.M. Salam, C.L. Quave. Opportunities for plant natural products in infection control. Current Opinion in Microbiology 45 (2018) 189-194. https://doi.org/10.1016/j.mib.2018.08.004 DOI: https://doi.org/10.1016/j.mib.2018.08.004
[9] H.S. França, L. Rocha, C.P. Fernandes, A.L.T.G. Ruiz, J.E. de Carvalho. Antiproliferative activity of the hexanic extract and phloroglucinols from Hypericum brasiliense. Revista Brasileira de Farmacognosia 23 (2013) 844-847. https://doi.org/10.1590/S0102-695X2013000500018 DOI: https://doi.org/10.1590/S0102-695X2013000500018
[10] L. Rocha, A. Marston, M. Auxiliadora, C. Kaplan, H. Stoeckli-Evans, U. Thull, B. Testa, K. Hostettmann. An antifungal γ-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense. Phytochemistry 36 (1994) 1381-1385. https://doi.org/10.1016/S0031-9422(00)89727-7 DOI: https://doi.org/10.1016/S0031-9422(00)89727-7
[11] L. Rocha, A. Marston, O. Potterat, M.A.C. Kaplan, H. Stoeckli-Evans, K. Hostettmann. Antibacterial phloroglucinols and flavonoids from Hypericum brasiliense. Phytochemistry 40 (1995) 1447-1452. https://doi.org/10.1016/0031-9422(95)00507-4 DOI: https://doi.org/10.1016/0031-9422(95)00507-4
[12] H.S. França, R.M. Kuster, P.D.N. Rito, A.P. De Oliveira, L.A. Teixeira, L. Rocha. Atividade antibacteriana de floroglucinóis e do extrato hexânico de Hypericum brasiliense Choysi. Química Nova 32 (2009) 1103-1106. https://doi.org/10.1590/S0100-40422009000500004 DOI: https://doi.org/10.1590/S0100-40422009000500004
[13] R. Pereira, L. Soares, P. Andre, F. Ramos, J. Scaffo, A.L. Corrêa, T. Aparecida, N. Ribeiro, D. Sachs, L. Rocha, F. Aguiar-alves. Hypericum brasiliense : bactericidal and antibiofilm activity against Staphylococcus aureus in vitro. Natural Product Research 36 (2022) 2643-2647 https://doi.org/10.1080/14786419.2021.1915306 DOI: https://doi.org/10.1080/14786419.2021.1915306
[14] A.S. Viana, A.M.N. Botelho, A.M. Moustafa, C.L.K. Boge, A.L.P. Ferreira, M.C. da Silva Carvalho, M.A. Guimarães, B. de Souza Scramignon Costa, M.C. de Mattos, S.P. Maciel, J. Echevarria-Lima, A. Narechania, K. O’Brien, C. Ryan, J.S. Gerber, B.T.F. Carvalho, A.M.S. Figueiredo, P.J. Planet. Multidrug-resistant methicillin-resistant Staphylococcus aureus associated with bacteremia and monocyte evasion, Rio de Janeiro, Brazil. Emerging Infectious Diseases 27 (2021) 2825-2835. https://doi.org/10.3201/eid2711.210097 DOI: https://doi.org/10.3201/eid2711.210097
[15] L.C.S. Pinheiro, L.V.B. Hoelz, M.L.G. Ferreira, L.G. Oliveira, R.F.A. Pereira. Synthesis of benzoylthiourea derivatives and analysis of their antibacterial performance against planktonic Staphylococcus aureus and its biofilms. Letters in Applied Microbiology 71 (2020) 645-651. https://doi.org/10.1111/lam.13359 DOI: https://doi.org/10.1111/lam.13359
[16] S. Xia, L. Ma, G. Wang, J. Yang, M. Zhang, X. Wang, J. Su, M. Xie. In vitro Antimicrobial activity and the mechanism of berberine against methicillin-resistant Staphylococcus aureus isolated from bloodstream infection patients. Infection and Drug Resistance 15 (2022) 1933-1944. https://doi.org/10.2147/idr.s357077 DOI: https://doi.org/10.2147/IDR.S357077
[17] A.C.M. Galdino, L. Viganor, M.M. Pereira, M. Devereux, M. McCann, M.H. Branquinha, Z. Molphy, S. O’Carroll, C. Bain, G. Menounou, A. Kellett, A.L.S. Santos. Copper(II) and silver(I)-1,10-phenanthroline-5,6-dione complexes interact with double-stranded DNA: further evidence of their apparent multi-modal activity towards Pseudomonas aeruginosa. JBIC Journal of Biological Inorganic Chemistry 27 (2022) 201-213. https://doi.org/10.1007/s00775-021-01922-3 DOI: https://doi.org/10.1007/s00775-021-01922-3
[18] N. Cerca, S. Martins, F. Cerca, K.K. Jefferson, G.B. Pier, R. Oliveira, J. Azeredo. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. Journal of Antimicrobial Chemotherapy 56 (2005) 331-336. https://doi.org/10.1093/jac/dki217 DOI: https://doi.org/10.1093/jac/dki217
[19] S. Pengfei, L. Yaqian, X. Lanlan, L. Zehao, L. Yimin, L. Shasha, L. Linhui, Y. Yifan, Z. Linying, W. Yong. L007-0069 kills Staphylococcus aureus in high resistant phenotypes. Cellular and Molecular Life Sciences: CMLS 79 (2022) 552. https://doi.org/10.1007/s00018-022-04588-5 DOI: https://doi.org/10.1007/s00018-022-04588-5
[20] K.L. Painter, E. Strange, J. Parkhill, K.B. Bamford, D. Armstrong-James, A.M. Edwards. Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response. Infection and Immunity 83 (2015) 1830-1844. https://doi.org/10.1128/iai.03016-14 DOI: https://doi.org/10.1128/IAI.03016-14
[21] S. Croes, R.H. Deurenberg, M.L.L. Boumans, P.S. Beisser, C. Neef, E.E. Stobberingh. Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage. BMC Microbiology 9 (2009) 229. https://doi.org/10.1186/1471-2180-9-229 DOI: https://doi.org/10.1186/1471-2180-9-229
[22] A. Ramírez-Granillo, L.A. Bautista-Hernández, V.M. Bautista-De Lucío, F.S. Magaña-Guerrero, A. Domínguez-López, I.M. Córdova-Alcántara, N.O. Pérez, M. de los A. Martínez-Rivera, A.V. Rodríguez-Tovar. Microbial warfare on three fronts: mixed biofilm of Aspergillus fumigatus and Staphylococcus aureus on primary cultures of human limbo-corneal fibroblasts. Frontiers in Cellular and Infection Microbiology 11 (2021) 646054. https://doi.org/10.3389/fcimb.2021.646054 DOI: https://doi.org/10.3389/fcimb.2021.646054
[23] L.C. Guimarães, B.M. de Souza, C. de Oliveira Whitaker, F. Abreu, R.B.R. Ferreira, K.R.N. dos Santos. Increased biofilm formation by Staphylococcus aureus clinical isolates on surfaces covered with plasma proteins. Journal of Medical Microbiology 70 (2021). https://doi.org/10.1099/jmm.0.001389 DOI: https://doi.org/10.1099/jmm.0.001389
[24] T.P. Mello, M.H. Branquinha, A.L.S. Santos. Biofilms formed by Scedosporium and Lomentospora species: focus on the extracellular matrix. Biofouling 36 (2020) 308-318. https://doi.org/10.1080/08927014.2020.1759558 DOI: https://doi.org/10.1080/08927014.2020.1759558
[25] S. Shivaji, B. Nagapriya, K. Ranjith. Differential susceptibility of mixed polymicrobial biofilms involving ocular coccoid bacteria (Staphylococcus aureus and S. epidermidis) and a filamentous fungus (Fusarium solani) on ex vivo human corneas. Microorganisms 11 (2023) 413. https://doi.org/10.3390/microorganisms11020413 DOI: https://doi.org/10.3390/microorganisms11020413
[26] M. Ahmed, D. Rooney, M. McCann, M. Devereux, B. Twamley, A.C.M. Galdino, L.S. Sangenito, L.O.P. Souza, M.C. Lourenço, K. Gomes, A.L.S. Santos. Synthesis and antimicrobial activity of a phenanthroline-isoniazid hybrid ligand and its Ag+ and Mn2+ complexes. BioMetals 32 (2019) 671-682. https://doi.org/10.1007/s10534-019-00204-5 DOI: https://doi.org/10.1007/s10534-019-00204-5
[27] H.F. Frota, C.M.A. Lorentino, P.F. Barbosa, L.S. Ramos, I.C. Barcellos, L. Giovanini, L.O.P. Souza, S.S.C. Oliveira, O.O. Abosede, A.S. Ogunlaja, M.M. Pereira, M.H. Branquinha, A.L.S. Santos. Antifungal potential of the new copper(II)-theophylline/1,10-phenanthroline complex against drug-resistant Candida species. BioMetals 37 (2024) 321-336. https://doi.org/10.1007/s10534-023-00549-y DOI: https://doi.org/10.1007/s10534-023-00549-y
[28] G. Indrayanto, G.S. Putra, F. Suhud. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles of Drug Substances, Excipients and Related Methodology 46 (2021) 273-307. https://doi.org/10.1016/bs.podrm.2020.07.005 DOI: https://doi.org/10.1016/bs.podrm.2020.07.005
[29] Y. Gu, Z. Yu, Y. Wang, L. Chen, C. Lou, C. Yang, W. Li, G. Liu, Y. Tang. admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties. Nucleic Acids Research 52 (2024) W432-W438. https://doi.org/10.1093/nar/gkae298 DOI: https://doi.org/10.1093/nar/gkae298
[30] Y. Myung, A.G.C. De Sá, D.B. Ascher. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Research 52 (2024) W469-W475. https://doi.org/10.1093/nar/gkae254 DOI: https://doi.org/10.1093/nar/gkae254
[31] J.D. Hughes, J. Blagg, D.A. Price, S. Bailey, G.A. DeCrescenzo, R. V. Devraj, E. Ellsworth, Y.M. Fobian, M.E. Gibbs, R.W. Gilles, N. Greene, E. Huang, T. Krieger-Burke, J. Loesel, T. Wager, L. Whiteley, Y. Zhang. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & Medicinal Chemistry Letters 18 (2008) 4872-4875. https://doi.org/10.1016/j.bmcl.2008.07.071 DOI: https://doi.org/10.1016/j.bmcl.2008.07.071
[32] C. de la Fuente-Nunez, A. Cesaro, R.E.W. Hancock. Antibiotic failure: Beyond antimicrobial resistance. Drug Resistance Updates 71 (2023) 101012. https://doi.org/10.1016/j.drup.2023.101012 DOI: https://doi.org/10.1016/j.drup.2023.101012
[33] S. Gibbons, B. Ohlendorf, I. Johnsen. The genus Hypericum—a valuable resource of anti-Staphylococcal leads. Fitoterapia 73 (2002) 300-304. https://doi.org/10.1016/s0367-326x(02)00082-5 DOI: https://doi.org/10.1016/S0367-326X(02)00082-5
[34] J. Karslake, J. Maltas, P. Brumm, K.B. Wood. Population density modulates drug inhibition and gives rise to potential bistability of treatment outcomes for bacterial infections. PLoS Computational Biology 12 (2016) e1005098. https://doi.org/10.1371/journal.pcbi.1005098 DOI: https://doi.org/10.1371/journal.pcbi.1005098
[35] D. Pletzer, R.E.W. Hancock. Is synergy the key to treating high-density infections? Future Microbiology 13 (2018) 1629-1632. https://doi.org/10.2217/fmb-2018-0216 DOI: https://doi.org/10.2217/fmb-2018-0216
[36] J. Li, S. Xie, S. Ahmed, F. Wang, Y. Gu, C. Zhang, X. Chai, Y. Wu, J. Cai, G. Cheng. Antimicrobial activity and resistance: influencing factors. Frontiers in Pharmacology 8 (2017) 364. https://doi.org/10.3389/fphar.2017.00364 DOI: https://doi.org/10.3389/fphar.2017.00364
[37] S. Cheng, R. Su, L. Song, X. Bai, H. Yang, Z. Li, Z. Li, X. Zhan, X. Xia, X. Lü, C. Shi. Citral and trans-cinnamaldehyde, two plant-derived antimicrobial agents can induce Staphylococcus aureus into VBNC state with different characteristics. Food Microbiology 112 (2023) 104241. https://doi.org/10.1016/j.fm.2023.104241 DOI: https://doi.org/10.1016/j.fm.2023.104241
[38] A.A. Tayel, S.M. Shaban, S.H. Moussa, N.M. Elguindy, A.M. Diab, K.E. Mazrou, R.A. Ghanem, S.M. El-Sabbagh. Bioactivity and application of plant seeds’ extracts to fight resistant strains of Staphylococcus aureus. Annals of Agricultural Sciences 63 (2018) 47-53. https://doi.org/10.1016/j.aoas.2018.04.006 DOI: https://doi.org/10.1016/j.aoas.2018.04.006
[39] A. Juma, P. Lemoine, A.B.J. Simpson, J. Murray, B.M.G. O’Hagan, P.J. Naughton, J.G. Dooley, I.M. Banat. Microscopic investigation of the combined use of antibiotics and biosurfactants on methicillin resistant Staphylococcus aureus. Frontiers in Microbiology 11 (2020) 532216. https://doi.org/10.3389/fmicb.2020.01477 DOI: https://doi.org/10.3389/fmicb.2020.01477
[40] M. Nega, P.M. Tribelli, K. Hipp, M. Stahl, F. Götz. New insights in the coordinated amidase and glucosaminidase activity of the major autolysin (Atl) in Staphylococcus aureus. Communications Biology 3 (2020) 695. https://doi.org/10.1038/s42003-020-01405-2 DOI: https://doi.org/10.1038/s42003-020-01405-2
[41] G.S. Dimech, L.A.L. Soares, M.A. Ferreira, A.G.V. De Oliveira, M.D.C. Carvalho, E.A. Ximenes. Phytochemical and antibacterial investigations of the extracts and fractions from the stem bark of Hymenaea stigonocarpa Mart. ex Hayne and effect on ultrastructure of Staphylococcus aureus induced by hydroalcoholic extract. The Scientific World Journal 2013 (2013) 862763. https://doi.org/10.1155/2013/862763 DOI: https://doi.org/10.1155/2013/862763
[42] F. Li, D. Zhai, Z. Wu, Y. Zhao, D. Qiao, X. Zhao. Impairment of the cell wall ligase, LytR-CpsA-Psr protein (LcpC), in methicillin resistant Staphylococcus aureus reduces its resistance to antibiotics and infection in a mouse model of sepsis. Frontiers in Microbiology 11 (2020) 557. https://doi.org/10.3389/fmicb.2020.00557 DOI: https://doi.org/10.3389/fmicb.2020.00557
[43] J. Zeng, D. Chen, C. Lv, K. Qin, Q. Zhou, N. Pu, S. Song, X. Wang. Antimicrobial and anti-biofilm activity of Polygonum chinense L.aqueous extract against Staphylococcus aureus. Scientific Reports 12 (2022) 21988. https://doi.org/10.1038/s41598-022-26399-1 DOI: https://doi.org/10.1038/s41598-022-26399-1
[44] J. Dai, M. Bai, C. Li, W. San Cheang, H. Cui, L. Lin. Antibacterial properties of citral against Staphylococcus aureus: From membrane damage to metabolic inhibition. Food Bioscience 53 (2023) 102770. https://doi.org/10.1016/j.fbio.2023.102770 DOI: https://doi.org/10.1016/j.fbio.2023.102770
[45] A.G. Al-Bakri, F.U. Afifi. Evaluation of antimicrobial activity of selected plant extracts by rapid XTT colorimetry and bacterial enumeration. Journal of Microbiological Methods 68 (2007) 19-25. https://doi.org/10.1016/j.mimet.2006.05.013 DOI: https://doi.org/10.1016/j.mimet.2006.05.013
[46] G.Y. Liu, A. Essex, J.T. Buchanan, V. Datta, H.M. Hoffman, J.F. Bastian, J. Fierer, V. Nizet. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. Journal of Experimental Medicine 202 (2005) 209-215. https://doi.org/10.1084/jem.20050846 DOI: https://doi.org/10.1084/jem.20050846
[47] M.A. Kohanski, D.J. Dwyer, B. Hayete, C.A. Lawrence, J.J. Collins. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 (2007) 797-810. https://doi.org/10.1016/j.cell.2007.06.049 DOI: https://doi.org/10.1016/j.cell.2007.06.049
[48] M. Otto. Staphylococcal biofilms. Microbiology Spectrum 6 (2018). https://doi.org/10.1128/microbiolspec.gpp3-0023-2018 DOI: https://doi.org/10.1128/microbiolspec.GPP3-0023-2018
[49] L.R. Hoffman, D.A. D’Argenio, M.J. MacCoss, Z. Zhang, R.A. Jones, S.I. Miller. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005 436:7054 436 (2005) 1171-1175. https://doi.org/10.1038/nature03912 DOI: https://doi.org/10.1038/nature03912
[50] J. Chen, H. Zhou, J. Huang, R. Zhang, X. Rao. Virulence alterations in Staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics. Journal of Advanced Research 31 (2021) 165-175. https://doi.org/10.1016/j.jare.2021.01.008 DOI: https://doi.org/10.1016/j.jare.2021.01.008
[51] C.L. Costa, C.P. de Azevedo, C. Quesada-Gómez, G.A. de C. Brito, M. da S. Regueira-Neto, G.M. de M. Guedes, M.F.G. Rocha, J.J.C. Sidrim, R. de A. Cordeiro, C.B.M. de Carvalho, D. de S.C.M. Castelo-Branco. Inhibitory effect of Brazilian red propolis on planktonic and biofilm forms of Clostridioides difficile. Anaerobe 69 (2021) 102322. https://doi.org/10.1016/j.anaerobe.2021.102322 DOI: https://doi.org/10.1016/j.anaerobe.2021.102322
[52] L.A. Schurig-Briccio, T. Yano, H. Rubin, R.B. Gennis. Characterization of the Type 2 NADH: menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. Biochimica et Biophysica Acta 1837 (2014) 954. https://doi.org/10.1016/j.bbabio.2014.03.017 DOI: https://doi.org/10.1016/j.bbabio.2014.03.017
[53] S.A. Henry, C.M. Webster, L.N. Shaw, N.J. Torres, M.E. Jobson, B.C. Totzke, J.K. Jackson, J.E. McGreig, M.N. Wass, G.K. Robinson, M. Shepherd. Steroid drugs inhibit bacterial respiratory oxidases and are lethal toward methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases 230 (2024) e149-e158. https://doi.org/10.1093/infdis/jiad540 DOI: https://doi.org/10.1093/infdis/jiad540
[54] J. Le Zhou, H.H. Chen, J. Xu, M.Y. Huang, J.F. Wang, H.J. Shen, S.X. Shen, C.X. Gao, C.D. Qian. Myricetin acts as an inhibitor of type II NADH dehydrogenase from Staphylococcus aureus. Molecules 29 (2024) 2354. https://doi.org/10.3390/molecules29102354 DOI: https://doi.org/10.3390/molecules29102354
[55] A. Grauel, J. Kägi, T. Rasmussen, I. Makarchuk, S. Oppermann, A.F.A. Moumbock, D. Wohlwend, R. Müller, F. Melin, S. Günther, P. Hellwig, B. Böttcher, T. Friedrich. Structure of Escherichia coli cytochrome bd-II type oxidase with bound aurachin D. Nature Communications 12 (2021) 6498. https://doi.org/10.1038/s41467-021-26835-2 DOI: https://doi.org/10.1038/s41467-021-26835-2
©2026 by the authors; licensee IAPC, Zagreb, Croatia. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/)
[56] M. Pagano, C. Faggio. The use of erythrocyte fragility to assess xenobiotic cytotoxicity. Cell Biochemistry and Function 33 (2015) 351-355. https://doi.org/10.1002/cbf.3135 DOI: https://doi.org/10.1002/cbf.3135
[57] M. Tacherfiout, S. Kherbachi, M. Kheniche, M. Mattonai, I. Degano, E. Ribechini, B. Khettal. HPLC-DAD and HPLC-ESI-MS-MS profiles of hydroalcoholic extracts of Chamaemelum nobile and Mentha pulegium, and study of their antihemolytic activity against AAPH-induced hemolysis. South African Journal of Botany 150 (2022) 678-690. https://doi.org/10.1016/j.sajb.2022.08.001 DOI: https://doi.org/10.1016/j.sajb.2022.08.001
[58] M. Yasir, N. Jamil, A. Nazir, Q. Kanwal, Mehr-un-Nisa, N. Athir, R. Mustafa, S.H. Al-Mijalli, M. Iqbal, N. Ahmad. Hemolytic activity and protective potential of Lamiaceae plants seed extracts and their bioactive components profiling having potential for functional foods and nutraceutical formulations. Biocatalysis and Agricultural Biotechnology 46 (2022) 102556. https://doi.org/10.1016/j.bcab.2022.102556 DOI: https://doi.org/10.1016/j.bcab.2022.102556
[59] I. Tsamesidis, G.K. Pouroutzidou, E. Lymperaki, K. Kazeli, C.B. Lioutas, E. Christodoulou, P. Perio, K. Reybier, A. Pantaleo, E. Kontonasaki. Effect of ion doping in silica-based nanoparticles on the hemolytic and oxidative activity in contact with human erythrocytes. Chemico-Biological Interactions 318 (2020) 108974. https://doi.org/10.1016/j.cbi.2020.108974 DOI: https://doi.org/10.1016/j.cbi.2020.108974
[60] A.O. Akinboye, I.M. Famuyide, I.M. Petzer, L.J. McGaw. In vitro antibacterial activity of selected South African plants against drug-resistant staphylococci isolated from clinical cases of bovine mastitis. Applied Sciences 13 (2023) 5560. https://doi.org/10.3390/app13095560 DOI: https://doi.org/10.3390/app13095560
[61] S. Fontanay, M. Grare, J. Mayer, C. Finance, R.E. Duval. Ursolic, oleanolic and betulinic acids: Antibacterial spectra and selectivity indexes. Journal of Ethnopharmacology 120 (2008) 272-276. https://doi.org/10.1016/j.jep.2008.09.001 DOI: https://doi.org/10.1016/j.jep.2008.09.001
[62] P. Verderio, M. Lecchi, C.M. Ciniselli, B. Shishmani, G. Apolone, G. Manenti. 3Rs principle and legislative decrees to achieve high standard of animal research. Animals 13 (2023) 277. https://doi.org/10.3390/ani13020277 DOI: https://doi.org/10.3390/ani13020277
[63] D.R. Silva, P.L. Rosalen, I.A. Freires, J. de C.O. Sardi, R.F. Lima, J.G. Lazarini, T.K.V.L. da Costa, J.V. Pereira, G.P. Godoy, E.M.M. de B. Costa. Anadenanthera Colubrina vell Brenan: anti-Candida and antibiofilm activities, toxicity and therapeutical action. Brazilian Oral Research 33 (2019) e023. https://doi.org/10.1590/1807-3107bor-2019.vol33.0023 DOI: https://doi.org/10.1590/1807-3107bor-2019.vol33.0023
[64] V.M. Meccatti, L.M.A. Figueiredo-Godoi, T.C. Pereira, P.M.N. de Lima, A. Abu Hasna, L.B. Senna, M.C. Marcucci, J.C. Junqueira, L.D. de Oliveira. The biocompatibility and antifungal effect of Rosmarinus officinalis against Candida albicans in Galleria mellonella model. Scientific Reports 12 (2022)15611. https://doi.org/10.1038/s41598-022-19425-9 DOI: https://doi.org/10.1038/s41598-022-19425-9
[65] X. Sun, N. Li, P. Zhong, L. Chen, J. Sun. Development of MAO-A and 5-HT2AR dual inhibitors with improved antidepressant activity. Journal of Medicinal Chemistry 65 (2022) 13385-13400. https://doi.org/10.1021/acs.jmedchem.2c01271 DOI: https://doi.org/10.1021/acs.jmedchem.2c01271
[66] F. Alqahtani, M. Alanazi, W. Alassaf, F.S. Aleanizy, M. Aljahany, M. Joseph, M. AlRaye. Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions. Journal of Complementary & Integrative Medicine 19 (2021) 383-388. https://doi.org/10.1515/jcim-2020-0422 DOI: https://doi.org/10.1515/jcim-2020-0422
[67] M.S. Attia, M.T. Elsebaey, G. Yahya, H. Chopra, M.A. Marzouk, A. Yahya, A.S. Abdelkhalek. Pharmaceutical polymers and p-glycoprotein: current trends and possible outcomes in drug delivery. Materials Today Communications 34 (2023) 371-406. https://doi.org/10.1016/j.mtcomm.2023.105318 DOI: https://doi.org/10.1016/j.mtcomm.2023.105318
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julia Chaves Scaffo, Sofia Trindade Mussi da Silva, Vitor Won-Held Rabelo, Leandro Stefano Sangenito, Lucas da Silva Abreu, Thaís P. Mello, Leandro Rocha, André Luis Souza dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
